IN a recent publication, Dundee, Barren and King (1960) reported that methylation of the thiobarbiturate, Inactin, produced a compound (B.I 37) which caused a prohibitively high incidence of spontaneous abnormal muscle movements. It was concluded that the drug was unsuitable for clinical use.